BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16264904)

  • 1. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?
    Haffty BG
    Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalizing cancer care: updates on head and neck cancer.
    de Souza JA; Cohen EE
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1219-22. PubMed ID: 19761425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current role of gene therapy in head and neck cancer.
    Ganly I; Soutar DS; Kaye SB
    Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of the neck in patients with head and neck squamous cell cancer: imaging techniques and biomarkers.
    Takes RP
    Oral Oncol; 2004 Aug; 40(7):656-67. PubMed ID: 15172634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives.
    Lallemant B; Evrard A; Chambon G; Sabra O; Kacha S; Lallemant JG; Lumbroso S; Brouillet JP
    Head Neck; 2010 Dec; 32(12):1712-9. PubMed ID: 20949446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors for head and neck cancer].
    Fujieda S
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):440-7. PubMed ID: 11329776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis.
    Chow TL; Lee DT; Choi CY; Chan TT; Lam SH
    Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival?
    Almadori G; Bussu F; Paludetti G
    Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):117-26. PubMed ID: 18327030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biomarkers in HNSCC: prognostic and therapeutic implications.
    Hussein MR; Cullen K
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):116-24. PubMed ID: 12113118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in squamous cell carcinomas of the head and neck.
    Liu M; Weynand B; Delos M; Marbaix E
    Acta Otorhinolaryngol Belg; 1999; 53(3):155-60. PubMed ID: 10635383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis for the metastasis of squamous cell carcinoma of the head and neck].
    Kakurina GV; Kondakova IV; Choĭnzonov EL
    Vopr Onkol; 2012; 58(1):26-32. PubMed ID: 22629824
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer.
    Le QT; Giaccia AJ
    Clin Cancer Res; 2003 Oct; 9(12):4287-95. PubMed ID: 14555497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of patients with metastatic cancer of unknown primary.
    Ghosh L; Dahut W; Kakar S; Posadas EM; Torres CG; Cancel-Santiago R; Ghosh BC
    Curr Probl Surg; 2005 Jan; 42(1):12-66. PubMed ID: 15711508
    [No Abstract]   [Full Text] [Related]  

  • 14. Metastatic cutaneous squamous cell carcinoma to the parotid and cervical lymph nodes: treatment and outcomes.
    Bumpous J
    Curr Opin Otolaryngol Head Neck Surg; 2009 Apr; 17(2):122-5. PubMed ID: 19346945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival.
    Oddone N; Morgan GJ; Palme CE; Perera L; Shannon J; Wong E; Gebski V; Veness MJ
    Cancer; 2009 May; 115(9):1883-91. PubMed ID: 19224549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance.
    Kim SH; Lee SY; Park HR; Sung JM; Park AR; Kang S; Kim BG; Choi YP; Kim YB; Cho NH
    Cancer; 2011 May; 117(9):1864-73. PubMed ID: 21509763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of molecular analysis in detecting cervical lymph node metastasis in head and neck squamous cell carcinoma.
    Elsheikh MN; Rinaldo A; Hamakawa H; Mahfouz ME; Rodrigo JP; Brennan J; Devaney KO; Grandis JR; Ferlito A
    Head Neck; 2006 Sep; 28(9):842-9. PubMed ID: 16691557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of micrometastatic tumor cells in head and neck squamous cell carcinoma. A possible predictor of recurrences?
    Guney K; Yoldas B; Ozbilim G; Derin AT; Sarihan S; Balkan E
    Saudi Med J; 2007 Feb; 28(2):216-20. PubMed ID: 17268699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of molecular markers in the management of head and neck cancers.
    Ferreira MB; De Souza JA; Cohen EE
    Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.